
ESTRO/LinkedIn
Jul 5, 2025, 04:33
ESTRO – CBCT vs. MR: Which will Lead the Future of Online Adaptive Radiotherapy?
European Society for Radiotherapy and Oncology (ESTRO) posted on LinkedIn:
“At ESTRO25, a heated debate unfolded: “CBCT-based fast adaptation workflows will supersede MR-Linac usage.”
With strong arguments on both sides, the audience shifted from 72% in favour to a near 50/50 split by the end.
Read the full Congress Report by the ESTRO Positioning and Immobilisation Focus Group to explore the clinical, economic, and strategic dimensions of this key discussion.”
More posts featuring European Society for Radiotherapy and Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 04:23
Jul 4, 2025, 19:49
Jul 4, 2025, 19:40
Jul 4, 2025, 19:09
Jul 4, 2025, 17:59
Jul 4, 2025, 17:47